Cooper Companies (COO) vs Medline (MDLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Medline is the larger company by market cap ($47.70 billion vs $10.41 billion), about 4.6 times the size. On valuation, Cooper Companies trades at a lower forward P/E (11.7x vs 22.5x for Medline). Cooper Companies converts more of its revenue into profit, with a net margin of 9.2% versus 4.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COO | MDLN |
|---|---|---|
| Share price | $54.75 | $35.45 |
| Market cap | $10.41B | $47.70B |
| 1-day change | -2.98% | -0.28% |
| YTD return | -32.98% | -15.25% |
| 1-year return | -20.41% | — |
| 5-year return | -44.84% | — |
| P/E ratio (TTM) | 18.81 | 88.63 |
| Forward P/E | 11.67 | 22.48 |
| EPS (TTM) | $2.91 | $0.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.09B | $28.43B |
| Revenue growth (YoY) | +5.06% | — |
| Net income (latest FY) | $374.90M | $1.16B |
| Gross margin | 65.54% | 26.44% |
| Operating margin | 16.69% | 7.78% |
| Net margin | 9.16% | 4.08% |
| 52-week high | $89.83 | $50.88 |
| 52-week low | $51.01 | $31.49 |
| Distance from 52-week high | -39.05% | -30.32% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +20.18% | +25.53% |
| Average volume | 3.11M | 7.61M |
| Shares outstanding | 190.16M | 877.35M |
| Employees | 15,000 | 45,000 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Instruments & Supplies | Medical Instruments & Supplies |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medline is about 4.6 times larger than Cooper Companies by market value ($47.70B vs $10.41B).
- Medline trades at a higher earnings multiple (88.6x vs 18.8x trailing P/E).
- Cooper Companies is more profitable, keeping 9.2 cents of every revenue dollar as net income versus 4.1 cents for Medline.
About Cooper Companies
COO stock →The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical.
Healthcare · Medical Instruments & Supplies · 15,000 employees
About Medline
MDLN stock →Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally.
Healthcare · Medical Instruments & Supplies · 45,000 employees
COO vs MDLN FAQ
Which is bigger, Cooper Companies or Medline?
Medline (MDLN) is larger, with a market capitalization of $47.70B compared with $10.41B for Cooper Companies (COO).
Which has the lower P/E ratio, COO or MDLN?
COO has the lower trailing P/E at 18.8, versus 88.6 for MDLN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cooper Companies and Medline in the same industry?
Yes. Both are classified in the Medical Instruments & Supplies industry within the Healthcare sector.